Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases.

Perez Jesus A; Lopez Javier J; Badillo Claudia C Torres; Jaya Gill; Santosh Kesari; Peter Novak; Max Temnikov; Roman Byshovets; Oleg Bychkov

Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases.

Perez Jesus A, Lopez Javier J, Badillo Claudia C Torres, Jaya Gill, Santosh Kesari, Peter Novak, Max Temnikov, Roman Byshovets, Oleg Bychkov

Research output: Contribution to journal › Article

Abstract

[This corrects the article DOI: 10.7759/cureus.29921.].

Original language	Undefined/Unknown
Journal	Articles, Abstracts, and Reports
State	Published - Oct 1 2022

Access to Document

http://digitalcommons.psjhealth.org/publications/6709

Cite this

Jesus A, P., Javier J, L., Claudia C Torres, B., Gill, J., Kesari, S., Novak, P., Temnikov, M., Byshovets, R., & Bychkov, O. (2022). Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases. Articles, Abstracts, and Reports. http://digitalcommons.psjhealth.org/publications/6709

@article{7249fdb3942c4ed9b43dc932761dae43,

title = "Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases.",

abstract = "[This corrects the article DOI: 10.7759/cureus.29921.].",

author = "\{Jesus A\}, Perez and \{Javier J\}, Lopez and \{Claudia C Torres\}, Badillo and Jaya Gill and Santosh Kesari and Peter Novak and Max Temnikov and Roman Byshovets and Oleg Bychkov",

year = "2022",

month = oct,

day = "1",

language = "Undefined/Unknown",

journal = "Articles, Abstracts, and Reports",

}

Jesus A, P, Javier J, L, Claudia C Torres, B, Gill, J, Kesari, S, Novak, P, Temnikov, M, Byshovets, R & Bychkov, O 2022, 'Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases.', Articles, Abstracts, and Reports. <http://digitalcommons.psjhealth.org/publications/6709>

TY - JOUR

T1 - Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases.

AU - Jesus A, Perez

AU - Javier J, Lopez

AU - Claudia C Torres, Badillo

AU - Gill, Jaya

AU - Kesari, Santosh

AU - Novak, Peter

AU - Temnikov, Max

AU - Byshovets, Roman

AU - Bychkov, Oleg

PY - 2022/10/1

Y1 - 2022/10/1

N2 - [This corrects the article DOI: 10.7759/cureus.29921.].

AB - [This corrects the article DOI: 10.7759/cureus.29921.].

M3 - Article

JO - Articles, Abstracts, and Reports

JF - Articles, Abstracts, and Reports

ER -